FNMTC

The familial forms of non-medullary thyroid carcinoma (FNMTC) represent 5% of thyroid neoplasms. To date, three FNMTC susceptibility genes have been identified (NKX2-1, DICER1 and SRGAP1). This study represents the first evidence of involvement of a germline FOXE1 rare variant in FNMTC etiology. This gene, which encodes the FOXE1 transcription factor involved in the morphogenesis and differentiation of the thyroid, may represent a novel susceptibility gene for this familial thyroid disease.

Authors and Affiliations:

As formas familiares de carcinoma não-medular da tiróide (FNMTC) representam cerca de 5% de todas as neoplasias da glândula tiroideia. Até à data, foram identificados três genes de susceptibilidade para o FNMTC (NKX2-1, DICER1 e SRGAP1). Este estudo apresentou, pela primeira vez, evidência do envolvimento a nível germinal de uma variante rara no gene FOXE1, na etiologia do FNMTC.